Aspect Partners’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
PCM
MWM
MNBTD
LSERS
SOADOR
PFSRSONJ
SBCM
YCM
Aspect Partners's NEO Position: Q2 2026 in Review
Aspect Partners opened a new position in NeoGenomics (NEO) in Q2 2026: 77 shares worth $1.12K. The stake represents ﹤0.01% of the portfolio and ranks #562 among its holdings.
43 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Aspect Partners held 77 shares of NeoGenomics worth $1.12K as of Q2 2026.
- NeoGenomics was a new Aspect Partners position in Q2 2026.
- NeoGenomics made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #562 holding.
- 43 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.